Sitagliptina Krka

Sitagliptina Krka is an oral diabetes medication containing sitagliptin, a DPP-4 inhibitor. It helps manage blood sugar levels in adults with type 2 diabetes. This EU-sourced treatment is taken once daily. Always consult a healthcare professional before use.

Sitagliptina Krka is primarily used to improve blood sugar control in adults with type 2 diabetes. It works alongside diet and exercise to regulate glucose levels. The medication is not intended for type 1 diabetes or diabetic ketoacidosis. It may be prescribed alongside other diabetes treatments as part of a broader management plan.

Sitagliptina Krka helps stabilize blood sugar levels by enhancing the body’s natural insulin response after meals. Users may notice more consistent energy levels and reduced sugar cravings. Some individuals report improved overall well-being when combined with lifestyle adjustments. Effects vary by person and should be monitored regularly.

Store Sitagliptina Krka at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your doctor about all medications and conditions before starting treatment. Regular blood sugar monitoring is recommended to assess effectiveness and safety.

Sitagliptina Krka may interact with other diabetes medications, including insulin or sulfonylureas, potentially increasing the risk of low blood sugar. Alcohol and certain diuretics can also affect blood glucose levels. Always disclose all prescriptions and over-the-counter products to your healthcare provider.